BenQ Medical Technology Corporation (TPEX:4116)
40.45
+0.30 (0.75%)
At close: Mar 6, 2026
BenQ Medical Technology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 949.33 | 863.19 | 830.51 | 979.78 | 369.85 |
Short-Term Investments | 286.38 | 282.69 | 323.17 | 187.12 | 49.34 |
Cash & Short-Term Investments | 1,236 | 1,146 | 1,154 | 1,167 | 419.19 |
Cash Growth | 7.84% | -0.68% | -1.13% | 178.37% | 22.34% |
Accounts Receivable | 968.55 | 905.41 | 846.48 | 840.49 | 201.27 |
Other Receivables | 9.26 | 11.52 | 53.87 | 9.38 | 5.27 |
Receivables | 977.81 | 916.93 | 900.35 | 849.87 | 206.54 |
Inventory | 892.88 | 783.13 | 515.75 | 493.03 | 216.06 |
Prepaid Expenses | - | 206.09 | 118.86 | 160.37 | 26.31 |
Other Current Assets | 586.21 | 46.29 | 43.7 | 51.07 | 2.08 |
Total Current Assets | 3,693 | 3,098 | 2,732 | 2,721 | 870.18 |
Property, Plant & Equipment | 723.63 | 1,175 | 1,068 | 1,003 | 742.75 |
Long-Term Investments | 115.06 | 20.12 | 0.12 | 34.42 | 131.12 |
Goodwill | - | 247.04 | 214.13 | 207.65 | 56.87 |
Other Intangible Assets | 427.09 | 148.12 | 120.3 | 140.68 | 29.96 |
Long-Term Accounts Receivable | - | 3.34 | 4.63 | 0.96 | - |
Long-Term Deferred Tax Assets | 32.42 | 26.76 | 25.22 | 31.44 | 19.62 |
Other Long-Term Assets | 459.81 | 555.34 | 547.04 | 551.46 | 104.8 |
Total Assets | 5,451 | 5,274 | 4,712 | 4,691 | 1,955 |
Accounts Payable | 606.97 | 624.4 | 529.01 | 555.43 | 148.73 |
Short-Term Debt | 894.53 | 580.7 | 384.47 | 399.07 | 50.27 |
Current Portion of Long-Term Debt | - | 84.83 | 8.63 | 17.9 | 35 |
Current Portion of Leases | 102.52 | 95.36 | 74.52 | 68.34 | 30.82 |
Current Income Taxes Payable | 44.58 | 43.14 | 55.51 | 58.79 | 18.51 |
Current Unearned Revenue | 35.31 | 29.48 | 32.38 | 56.17 | 25.24 |
Other Current Liabilities | 593.37 | 310.27 | 291.7 | 290.57 | 155.09 |
Total Current Liabilities | 2,277 | 1,768 | 1,376 | 1,446 | 463.65 |
Long-Term Debt | 534.37 | 868.95 | 843.13 | 404.76 | 331.25 |
Long-Term Leases | 218.63 | 276.17 | 261.08 | 226.65 | 44.41 |
Pension & Post-Retirement Benefits | - | 9.97 | 9.06 | 2.54 | 3.15 |
Long-Term Deferred Tax Liabilities | 46.64 | 43.4 | 32.37 | 36.51 | 9.25 |
Other Long-Term Liabilities | 42.94 | 6.89 | 9.97 | 8.46 | 3.8 |
Total Liabilities | 3,120 | 2,974 | 2,532 | 2,125 | 855.51 |
Common Stock | 445.66 | 445.66 | 445.66 | 445.66 | 445.66 |
Additional Paid-In Capital | 298.11 | 297.92 | 297.92 | 297.92 | 297.92 |
Retained Earnings | 386.45 | 380.59 | 361.81 | 457.38 | 297.44 |
Comprehensive Income & Other | -3.55 | -2.11 | -5.56 | 827.2 | -2.95 |
Total Common Equity | 1,127 | 1,122 | 1,100 | 2,028 | 1,038 |
Minority Interest | 1,204 | 1,178 | 1,081 | 537.78 | 61.71 |
Shareholders' Equity | 2,331 | 2,300 | 2,180 | 2,566 | 1,100 |
Total Liabilities & Equity | 5,451 | 5,274 | 4,712 | 4,691 | 1,955 |
Total Debt | 1,750 | 1,906 | 1,572 | 1,117 | 491.75 |
Net Cash (Debt) | -514.34 | -760.13 | -418.15 | 50.19 | -72.55 |
Net Cash Per Share | -11.51 | -16.96 | -9.33 | 1.12 | -1.62 |
Filing Date Shares Outstanding | 44.98 | 44.57 | 44.57 | 44.57 | 44.57 |
Total Common Shares Outstanding | 44.98 | 44.57 | 44.57 | 44.57 | 44.57 |
Working Capital | 1,415 | 1,330 | 1,356 | 1,275 | 406.53 |
Book Value Per Share | 25.05 | 25.18 | 24.68 | 45.51 | 23.29 |
Tangible Book Value | 699.59 | 726.9 | 765.39 | 1,680 | 951.24 |
Tangible Book Value Per Share | 15.55 | 16.31 | 17.17 | 37.69 | 21.34 |
Land | - | 346.86 | 346.86 | 346.86 | 282.49 |
Buildings | - | 364.38 | 364.56 | 362.78 | 362.72 |
Machinery | - | 823.2 | 698.4 | 636.01 | 291.98 |
Construction In Progress | - | 1.38 | 3.6 | - | - |
Leasehold Improvements | - | 158.38 | 138.99 | 150.83 | 53.66 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.